Cargando…

Diabetes and the Heart: Is There Objective Evidence of a Human Diabetic Cardiomyopathy?

Detalles Bibliográficos
Autor principal:	Litwin, Sheldon E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781487/ https://www.ncbi.nlm.nih.gov/pubmed/24065790 http://dx.doi.org/10.2337/db13-0683

Ejemplares similares

Evidence for human diabetic cardiomyopathy
por: Marfella, Raffaele, et al.
Publicado: (2021)

Inflammation attenuating lncRNAs in diabetic cardiomyopathy
por: Mohsin, Sadia, et al.
Publicado: (2023)

Exosomes in Diabetic Cardiomyopathy: The Next-Generation Therapeutic Targets?
por: Sahoo, Susmita, et al.
Publicado: (2016)

Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy
por: Ren, Jun, et al.
Publicado: (2014)

Comparative Effectiveness and the Future of Clinical Research in Diabetes
por: Greenfield, Sheldon
Publicado: (2013)

Diabetes in Early Pregnancy: Getting to the Heart of the Matter
por: Gilbert, Jeffrey S., et al.
Publicado: (2013)

FoxO1 breaks diabetic heart
por: Nagao, Mototsugu, et al.
Publicado: (2013)

Role of obesity and hypertension in the incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
por: Sala, Lucia La, et al.
Publicado: (2021)

Management of hyperglycemia in type 2 diabetes: evidence and uncertainty
por: Esposito, Katherine, et al.
Publicado: (2013)

C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter
por: Sattar, Naveed, et al.
Publicado: (2009)

Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
por: Bayeva, Marina, et al.
Publicado: (2013)

Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
por: Nakamura, Kazufumi, et al.
Publicado: (2022)

Unsticking the Broken Diabetic Heart: O-GlcNAcylation and Calcium Sensitivity
por: Wende, Adam R.
Publicado: (2015)

Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
por: Athithan, Lavanya, et al.
Publicado: (2019)

Clozapine-induced Gastrointestinal Hypomotility — New Objective Evidence for an Underestimated Side-effect()
por: Hasan, Alkomiet
Publicado: (2016)

Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction
por: Wende, Adam R., et al.
Publicado: (2020)

Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update
por: Tootee, Ali, et al.
Publicado: (2021)

Commentary: Mending a broken heart: The ongoing quest for mesenchymal stem cell therapy for ischemic cardiomyopathy
por: Spinetti, Gaia, et al.
Publicado: (2021)

Enzymatic and non-enzymatic post-translational modifications linking diabetes and heart disease
por: Yamamoto, Yasuhiko, et al.
Publicado: (2015)

Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues
por: Longo, Miriam, et al.
Publicado: (2022)

Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
por: Mekhaimar, Menatalla, et al.
Publicado: (2022)

To B or Not to B: (Anti)bodies of Evidence on the Crime Scene of Type 1 Diabetes?
por: Mallone, Roberto, et al.
Publicado: (2011)

Preserving mitochondria to treat hypertrophic cardiomyopathy: From rare mitochondrial DNA mutation to heart failure therapy?
por: Diwan, Abhinav
Publicado: (2023)

Nerve growth factor: Does this have the potential to become a miraculous treatment for diabetic heart?
por: Naruse, Keiko
Publicado: (2012)

Objective measurement of physical activity: improving the evidence base to address non-communicable diseases in Africa
por: Barr, Anna Louise, et al.
Publicado: (2018)

Diabetes Prevention: Vitamin D Supplementation May Not Provide Any Protection If There Is No Evidence of Deficiency!
por: Gröber, Uwe, et al.
Publicado: (2019)

A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
por: Bhalla, Vivek, et al.
Publicado: (2013)

Diabetes and its drivers: the largest epidemic in human history?
por: Zimmet, Paul Z.
Publicado: (2017)

Diabetic cardiomyopathy
por: Asghar, Omar, et al.
Publicado: (2009)

Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’
por: Evans, Marc
Publicado: (2018)

Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Screening for mutations in human cardiomyopathy- is RBM24 a new but rare disease gene?
por: Gaertner, Anna, et al.
Publicado: (2018)

The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
por: Czupryniak, Leszek, et al.
Publicado: (2021)

Indoor air as a vehicle for human pathogens: Introduction, objectives, and expectation of outcome
por: Sattar, Syed A.
Publicado: (2016)

The Imperative to Prevent Diabetes
por: Ratner, Robert E.
Publicado: (2012)

Myocyte [Na(+)](i) Dysregulation in Heart Failure and Diabetic Cardiomyopathy
por: Despa, Sanda
Publicado: (2018)

Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?
por: Marcinkiewicz, Anna, et al.
Publicado: (2017)

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy
por: Richter, Claudia, et al.
Publicado: (2021)

Metabolic Flexibility of Mitochondria Plays a Key Role in Balancing Glucose and Fatty Acid Metabolism in the Diabetic Heart
por: Gambardella, Jessica, et al.
Publicado: (2020)

Clocking in on Diabetic Retinopathy
por: Kleinman, Mark E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_871aq81vribmn10uqedn2eqr9g